A New Paradigm of Real-Time Data Assembly to Support Knowledge-Based Decision Making: A Case Study

A New Paradigm of Real-Time Data Assembly to Support Knowledge-Based Decision Making: A Case Study

Conference: DIA
Division: Cognigen

Real-time data assembly (RTDA) to support knowledgebased decision making was implemented for the development of a compound during Phase II. Program goals were to develop a data warehouse to expedite…

Comparison of Post-Operative Nosocomial Infection Associated with Blood Management Techniques in Cardiovascular and Orthopedic Surgery

Comparison of Post-Operative Nosocomial Infection Associated with Blood Management Techniques in Cardiovascular and Orthopedic Surgery

Conference: DIA
Division: Cognigen

Numerous risks are associated with allogeneic blood transfusions, however non-allogeneic blood options can minimize the use of allogeneic blood. This study compared infection rates associated with blood…

Data Analysis of High-Throughput Screening Results:  Application of Multidomain Clustering to the NCI Anti-HIV Data Set

Data Analysis of High-Throughput Screening Results:  Application of Multidomain Clustering to the NCI Anti-HIV Data Set

Publication: J Med Chem
Software: MedChem Studio™

The routine use of high-throughput screening (HTS) systems in the drug discovery process has resulted in an increasing need for fast, reliable analysis of massive amounts of data.

Rapid Assessment of Data Set Structures

Rapid Assessment of Data Set Structures

Authors: Vecchione P
Conference: Pharmaceutical Industry SAS Users Group (PharmaSUG)
Division: Cognigen

When SAS® data is received from an external source, such as a sponsor, CRO, or another department, it is important to assess the new data to determine if variables have been added or removed, locate…

Simultaneous Population Pharmacokinetic (PBK) Modeling of Irinotecan (CPT-11) and its Major Metabolites, SN 38 and SN-38G

Simultaneous Population Pharmacokinetic (PBK) Modeling of Irinotecan (CPT-11) and its Major Metabolites, SN 38 and SN-38G

Conference: ASCPT
Division: Cognigen

To develop a PPK model in NONMEM® that simultaneously predicts the plasma concentration (Cp) profiles of CPT-11 (C) and its metabolites, SN-38 (S) and SN-38G (G).

Uniqueness of Solutions to Compartmental Models of Population Pharmacokinetics for Drugs Undergoing Complex Metabolism

Uniqueness of Solutions to Compartmental Models of Population Pharmacokinetics for Drugs Undergoing Complex Metabolism

Conference: ASCPT
Division: Cognigen

To investigate parameter identifiability and uniqueness of solutions to compartmental population pharmacokinetic (PPK) models for drugs with complex metabolism.

Comparison of Laboratory Safety Data from Japanese and Non-Japanese in Linezolid Phase I Studies

Comparison of Laboratory Safety Data from Japanese and Non-Japanese in Linezolid Phase I Studies

Conference: ASCPT
Division: Cognigen

The laboratory safety data of linezolid (lzd) pooled from 6 multi-dose Phase I studies were compared in 65 Japanese (J) and 56 non-Japanese (non-J) subjects.

Comparison of Linezolid Pharmacokinetics from Phase I Studies of Japanese and Caucasians

Comparison of Linezolid Pharmacokinetics from Phase I Studies of Japanese and Caucasians

Conference: ASCPT
Division: Cognigen

This bridging analysis compared pharmacokinetic (PK) parameters for linezolid (lzd) observed in Japanese (J) and Caucasians (C) in traditional PK Phase I studies.

Pharmacodynamics in the evaluation of drug regimens

Pharmacodynamics in the evaluation of drug regimens

Publication: Ann Pharmacother
Division: Cognigen

We believe, especially in an era of increasing antimicrobial resistance, that the integration of PK/PD models and stochastic techniques provides a powerful new tool...

Population Pharmacodynamic (PD) Assessment of the Safety and Antiretroviral Activity of Atazanavir (BMS-232632)

Population Pharmacodynamic (PD) Assessment of the Safety and Antiretroviral Activity of Atazanavir (BMS-232632)

Conference: ICAAC
Division: Cognigen

Atazanavir (BMS-232632), currently in Phase III development, is a well-tolerated, once-daily protease inhibitor (PI) which does not appear to elevate cholesterol or triglyceride blood levels and has…

Population Pharmacokinetics/Pharmacodynamics of Antidepressant R,R(-) and S,S(+) Reboxetine (RBX)

Population Pharmacokinetics/Pharmacodynamics of Antidepressant R,R(-) and S,S(+) Reboxetine (RBX)

Conference: AAPS
Division: Cognigen

To develop a population pharmacokinetic model describing the disposition of each enantiomer of antidepressant reboxetine and a pharmacodynamic model relating plasma concentrations and adverse effects.

A population pharmacokinetic-pharmacodynamic analysis and model validation of azimilide

A population pharmacokinetic-pharmacodynamic analysis and model validation of azimilide

Publication: Clin Pharmacol Ther
Division: Cognigen

Pharmacokinetic (PK) and pharmacodynamic (PD) models for azimilide were developed and validated with sparse blood sampling and QTc interval data obtained

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

Publication: Adv Drug Deliv Rev
Software: GastroPlus®
Division: Simulations Plus

Recent advances in computational methods applied to the fields of drug delivery and biopharmaceutics will be reviewed with a focus on prediction of the impact of physiological and biochemical factors on...

A New Paradigm in Pediatric Drug Development: The Application of Cognitive Engineering

A New Paradigm in Pediatric Drug Development: The Application of Cognitive Engineering

Conference: DIA
Division: Cognigen

Design of clinical trials in pediatrics is complicated by sensitive ethical considerations, a small pool of appropriate study subjects, and difficulty in determining drug dosing regimens. Cognitive engineering…

Transcend Global and Corporate Boundaries During Drug Development

Transcend Global and Corporate Boundaries During Drug Development

Conference: DIA
Division: Cognigen

We developed an innovative and alternative web-based strategy which combines a hypertext environment with human intelligence and creativity to lead a scientific audience through complex statistical…